As of Friday, January 09, Rigel Pharmaceuticals, Inc.’s RIGL share price has dipped by 5.01%, which has investors questioning ...
Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.
Investor's Business Daily on MSN
Oric Pharmaceuticals stock sees healthy RS rating jump to 80
One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Oric Pharmaceuticals ORIC stock ...
Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.
If you are wondering whether Vertex Pharmaceuticals' current share price reflects its long term potential, a useful starting ...
Wondering if Recursion Pharmaceuticals at around US$4.67 a share is priced for its potential or still misunderstood by the ...
The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.
A Wells Fargo analyst cut his price target on Ultragenyx stock, though it still implies significant upside from yesterday's closing price. Ultragenyx reported yesterday that two Phase 3 studies failed ...
The recent news of Novo Nordisk’s nearly 10% stock decline – currently -6.6% – following disappointing Alzheimer’s trial results for its Ozempic pill highlights the volatility in pharmaceutical stocks ...
BridgeBio Pharma (BBIO) has priced its private offering of $550M aggregate principal amount of 0.75% convertible senior notes ...
Despite additional cost savings in 2026, Pfizer also forecasts that its adjusted earnings per share (EPS) will likely decline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results